TYK-00540 for adults with solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug, TYK-00540, for people with solid tumors that have not responded to or cannot tolerate standard treatments. It also looks at specific types of breast and ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid tumor that has spread or cannot be removed and standard treatments have stopped working or caused too many side effects.
- You are able to perform daily activities with little or no help (ECOG 0 or 1).
- Your major organs (like liver, kidneys, heart, and blood cells) are working well enough.
- You are willing to use effective birth control during and for 6 months after treatment.
- You have not had certain cancer treatments within the last 2 to 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet, TYK-00540, alone or with another drug, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests an experimental drug, TYK-01054, in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can help shrink or control the cancer.
This trial tests a new drug, GSK5533524, alone or with other treatments, for people with advanced solid tumors that have stopped responding to standard therapies. It aims to find out if the drug is safe and shows early signs of working.
This trial tests a new drug called SYH2095 for people with advanced solid tumors, including a specific type of breast cancer (HR+/HER2-). The goal is to see if it is safe and effective. You may join if you are an adult with a tumor that can be measured and you are in generally good health.
This trial tests a new drug called KY-0301 for people with advanced solid tumors that have not responded to standard treatments. The study has two parts: Part I includes various solid tumor types, while Part II focuses on specific cancers like non-small cell lung cancer or colorectal cancer.
This trial is testing a new tablet called YY2201 for people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can help shrink or control the tumor.
Hear when a new Locally Advanced or Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.